Adrenergic regulation of immune cell function and inflammation

Drashya Sharma, J David Farrar, Drashya Sharma, J David Farrar

Abstract

The sympathetic nervous system integrates the functions of multiple organ systems by regulating their autonomic physiological activities. The immune system is regulated both locally and systemically by the neurotransmitters epinephrine and norepinephrine secreted by the adrenal gland and local sympathetic neurons. Immune cells respond by activation of adrenergic receptors, primarily the β2-adrenergic receptor, which signal through heterotrimeric G-proteins. Depending upon the cell type, adrenergic signaling regulates a variety of functions in immune cells ranging from cellular migration to cytokine secretion. Furthermore, due to the diurnal oscillation of systemic norepinephrine levels, various immune functions follow a circadian rhythmic pattern. This review will highlight recent advances in our understanding of how the sympathetic nervous system regulates both innate and adaptive immune functions and how this regulation is linked to circadian rhythms.

References

    1. Lorton D, Bellinger DL. Molecular mechanisms underlying beta-adrenergic receptor-mediated cross-talk between sympathetic neurons and immune cells. Int J Mol Sci. 2015;16(3):5635–5665. doi: 10.3390/ijms16035635.
    1. Felten DL, Overhage JM, Felten SY, Schmedtje JF. Noradrenergic sympathetic innervation of lymphoid tissue in the rabbit appendix: further evidence for a link between the nervous and immune systems. Brain Res Bull. 1981;7(5):595–612. doi: 10.1016/0361-9230(81)90010-1.
    1. Williams JM, Felten DL. Sympathetic innervation of murine thymus and spleen: a comparative histofluorescence study. Anat Rec. 1981;199(4):531–542. doi: 10.1002/ar.1091990409.
    1. Williams JM, Peterson RG, Shea PA, Schmedtje JF, Bauer DC, Felten DL. Sympathetic innervation of murine thymus and spleen: evidence for a functional link between the nervous and immune systems. Brain Res Bull. 1981;6(1):83–94. doi: 10.1016/S0361-9230(81)80072-X.
    1. Felten DL, Felten SY, Carlson SL, Olschowka JA, Livnat S. Noradrenergic and peptidergic innervation of lymphoid tissue. J Immunol. 1985;135(2 Suppl):755s–765s.
    1. Felten DL, Ackerman KD, Wiegand SJ, Felten SY. Noradrenergic sympathetic innervation of the spleen: I. Nerve fibers associate with lymphocytes and macrophages in specific compartments of the splenic white pulp. J Neurosci Res. 1987;18(1):28–36. doi: 10.1002/jnr.490180107.
    1. Kendall MD, al-Shawaf AA. Innervation of the rat thymus gland. Brain Behav Immun. 1991;5(1):9–28. doi: 10.1016/0889-1591(91)90004-T.
    1. Kendall MD, Atkinson BA, Munoz FJ, de la Riva C, Clarke AG, von Gaudecker B. The noradrenergic innervation of the rat thymus during pregnancy and in the post partum period. J Anat. 1994;185(Pt 3):617–625.
    1. Reilly FD, McCuskey PA, Miller ML, McCuskey RS, Meineke HA. Innervation of the periarteriolar lymphatic sheath of the spleen. Tissue Cell. 1979;11(1):121–126. doi: 10.1016/0040-8166(79)90012-0.
    1. Villaro AC, Sesma MP, Vazquez JJ. Innervation of mouse lymph nodes: nerve endings on muscular vessels and reticular cells. Am J Anat. 1987;179(2):175–185. doi: 10.1002/aja.1001790210.
    1. Panuncio AL, De La Pena S, Gualco G, Reissenweber N. Adrenergic innervation in reactive human lymph nodes. J Anat. 1999;194(Pt 1):143–146. doi: 10.1046/j.1469-7580.1999.19410143.x.
    1. Nance DM, Sanders VM. Autonomic innervation and regulation of the immune system (1987-2007) Brain Behav Immun. 2007;21(6):736–745. doi: 10.1016/j.bbi.2007.03.008.
    1. Burgueno JF, Barba A, Eyre E, Romero C, Neunlist M, Fernandez E. TLR2 and TLR9 modulate enteric nervous system inflammatory responses to lipopolysaccharide. J Neuroinflammation. 2016;13(1):187. doi: 10.1186/s12974-016-0653-0.
    1. Zhao M, Zhou A, Xu L, Zhang X. The role of TLR4-mediated PTEN/PI3K/AKT/NF-kappaB signaling pathway in neuroinflammation in hippocampal neurons. Neuroscience. 2014;269:93–101. doi: 10.1016/j.neuroscience.2014.03.039.
    1. Helley MP, Abate W, Jackson SK, Bennett JH, Thompson SW. The expression of Toll-like receptor 4, 7 and co-receptors in neurochemical sub-populations of rat trigeminal ganglion sensory neurons. Neuroscience. 2015;310:686–698. doi: 10.1016/j.neuroscience.2015.09.069.
    1. Liu HY, Hong YF, Huang CM, Chen CY, Huang TN, Hsueh YP. TLR7 negatively regulates dendrite outgrowth through the Myd88-c-Fos-IL-6 pathway. J Neurosci. 2013;33(28):11479–11493. doi: 10.1523/JNEUROSCI.5566-12.2013.
    1. Kaul D, Habbel P, Derkow K, Kruger C, Franzoni E, Wulczyn FG, Bereswill S, Nitsch R, Schott E, Veh R, Naumann T, Lehnardt S. Expression of Toll-like receptors in the developing brain. PLoS One. 2012;7(5):e37767. doi: 10.1371/journal.pone.0037767.
    1. Peltier DC, Simms A, Farmer JR, Miller DJ. Human neuronal cells possess functional cytoplasmic and TLR-mediated innate immune pathways influenced by phosphatidylinositol-3 kinase signaling. J Immunol. 2010;184(12):7010–7021. doi: 10.4049/jimmunol.0904133.
    1. Ma Y, Haynes RL, Sidman RL, Vartanian T. TLR8: an innate immune receptor in brain, neurons and axons. Cell Cycle. 2007;6(23):2859–2868. doi: 10.4161/cc.6.23.5018.
    1. Spengler RN, Chensue SW, Giacherio DA, Blenk N, Kunkel SL. Endogenous norepinephrine regulates tumor necrosis factor-alpha production from macrophages in vitro. J Immunol. 1994;152(6):3024–3031.
    1. Grailer JJ, Haggadone MD, Sarma JV, Zetoune FS, Ward PA. Induction of M2 regulatory macrophages through the beta2-adrenergic receptor with protection during endotoxemia and acute lung injury. J Innate Immun. 2014;6(5):607–618. doi: 10.1159/000358524.
    1. Donnelly LE, Tudhope SJ, Fenwick PS, Barnes PJ. Effects of formoterol and salmeterol on cytokine release from monocyte-derived macrophages. Eur Respir J. 2010;36(1):178–186. doi: 10.1183/09031936.00158008.
    1. Agac D, Estrada LD, Maples R, Hooper LV, Farrar JD. The beta2-adrenergic receptor controls inflammation by driving rapid IL-10 secretion. Brain Behav Immun. 2018;74:176–185. doi: 10.1016/j.bbi.2018.09.004.
    1. Kizaki T, Shirato K, Sakurai T, Ogasawara JE, Oh-ishi S, Matsuoka T, Izawa T, Imaizumi K, Haga S, Ohno H. Beta2-adrenergic receptor regulate Toll-like receptor 4-induced late-phase NF-kappaB activation. Mol Immunol. 2009;46(6):1195–1203. doi: 10.1016/j.molimm.2008.11.005.
    1. Li Y, Li H, Zhang D. Timing of norepinephrine initiation in patients with septic shock: a systematic review and meta-analysis. Crit Care. 2020;24(1):488. doi: 10.1186/s13054-020-03204-x.
    1. Pollard S, Edwin SB, Alaniz C. Vasopressor and inotropic management of patients with septic shock. P T. 2015;40(7):438–450.
    1. Stolk RF, van der Poll T, Angus DC, van der Hoeven JG, Pickkers P, Kox M. Potentially inadvertent immunomodulation: norepinephrine use in sepsis. Am J Respir Crit Care Med. 2016;194(5):550–558. doi: 10.1164/rccm.201604-0862CP.
    1. Stolk RF, van der Pasch E, Naumann F, Schouwstra J, Bressers S, van Herwaarden AE, Gerretsen J, Schambergen R, Ruth MM, van der Hoeven JG, van Leeuwen H, Pickkers P, Kox M. Norepinephrine dysregulates the immune response and compromises host defense during sepsis. Am J Respir Crit Care Med. 2020;202(6):830–842. doi: 10.1164/rccm.202002-0339OC.
    1. van der Poll T, Coyle SM, Barbosa K, Braxton CC, Lowry SF. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest. 1996;97(3):713–719. doi: 10.1172/JCI118469.
    1. Kim B-J, Jones HP. Epinephrine-primed murine bone marrow-derived dendritic cells facilitate production of IL-17A and IL-4 but not IFN-γ by CD4+ T cells. Brain Behav Immun. 2010;24(7):1126–1136. doi: 10.1016/j.bbi.2010.05.003.
    1. Mizuno K, Takahashi HK, Iwagaki H, Katsuno G, Kamurul HA, Ohtani S, Mori S, Yoshino T, Nishibori M, Tanaka N. Beta2-adrenergic receptor stimulation inhibits LPS-induced IL-18 and IL-12 production in monocytes. Immunol Lett. 2005;101(2):168–172. doi: 10.1016/j.imlet.2005.05.008.
    1. Takenaka MC, Araujo LP, Maricato JT, Nascimento VM, Guereschi MG, Rezende RM, Quintana FJ, Basso AS. Norepinephrine controls effector T cell differentiation through beta2-adrenergic receptor-mediated inhibition of NF-kappaB and AP-1 in dendritic cells. J Immunol. 2016;196(2):637–644. doi: 10.4049/jimmunol.1501206.
    1. Wieduwild E, Girard-Madoux MJ, Quatrini L, Laprie C, Chasson L, Rossignol R, Bernat C, Guia S, Ugolini S (2020) beta2-adrenergic signals downregulate the innate immune response and reduce host resistance to viral infection. J Exp Med 214(4):e20190554. 10.1084/jem.20190554
    1. Frohman EM, Vayuvegula B, Gupta S, van den Noort S. Norepinephrine inhibits gamma-interferon-induced major histocompatibility class II (Ia) antigen expression on cultured astrocytes via beta-2-adrenergic signal transduction mechanisms. Proc Natl Acad Sci U S A. 1988;85(4):1292–1296. doi: 10.1073/pnas.85.4.1292.
    1. Neumann H, Boucraut J, Hahnel C, Misgeld T, Wekerle H. Neuronal control of MHC class II inducibility in rat astrocytes and microglia. Eur J Neurosci. 1996;8(12):2582–2590. doi: 10.1111/j.1460-9568.1996.tb01552.x.
    1. Seiffert K, Hosoi J, Torii H, Ozawa H, Ding W, Campton K, Wagner JA, Granstein RD. Catecholamines inhibit the antigen-presenting capability of epidermal Langerhans cells. J Immunol. 2002;168(12):6128–6135. doi: 10.4049/jimmunol.168.12.6128.
    1. Herve J, Dubreil L, Tardif V, Terme M, Pogu S, Anegon I, Rozec B, Gauthier C, Bach JM, Blancou P. beta2-Adrenoreceptor agonist inhibits antigen cross-presentation by dendritic cells. J Immunol. 2013;190(7):3163–3171. doi: 10.4049/jimmunol.1201391.
    1. Podojil JR, Sanders VM. CD86 and beta2-adrenergic receptor stimulation regulate B-cell activity cooperatively. Trends Immunol. 2005;26(4):180–185. doi: 10.1016/j.it.2005.02.005.
    1. Kohm AP, Mozaffarian A, Sanders VM. B cell receptor- and beta 2-adrenergic receptor-induced regulation of B7-2 (CD86) expression in B cells. J Immunol. 2002;168(12):6314–6322. doi: 10.4049/jimmunol.168.12.6314.
    1. Podojil JR, Sanders VM. Selective regulation of mature IgG1 transcription by CD86 and beta 2-adrenergic receptor stimulation. J Immunol. 2003;170(10):5143–5151. doi: 10.4049/jimmunol.170.10.5143.
    1. Staedtke V, Bai RY, Kim K, Darvas M, Davila ML, Riggins GJ, Rothman PB, Papadopoulos N, Kinzler KW, Vogelstein B, Zhou S. Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome. Nature. 2018;564(7735):273–277. doi: 10.1038/s41586-018-0774-y.
    1. Konig MF, Powell M, Staedtke V, Bai RY, Thomas DL, Fischer N, Huq S, Khalafallah AM, Koenecke A, Xiong R, Mensh B, Papadopoulos N, Kinzler KW, Vogelstein B, Vogelstein JT, Athey S, Zhou S, Bettegowda C. Preventing cytokine storm syndrome in COVID-19 using alpha-1 adrenergic receptor antagonists. J Clin Invest. 2020;130(7):3345–3347. doi: 10.1172/JCI139642.
    1. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O’Garra A, Murphy KM. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science. 1993;260(5107):547–549. doi: 10.1126/science.8097338.
    1. Pearce EL, Shen H. Generation of CD8 T cell memory is regulated by IL-12. J Immunol. 2007;179(4):2074–2081. doi: 10.4049/jimmunol.179.4.2074.
    1. Pipkin ME, Sacks JA, Cruz-Guilloty F, Lichtenheld MG, Bevan MJ, Rao A. Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity. 2010;32(1):79–90. doi: 10.1016/j.immuni.2009.11.012.
    1. Farrar JD, Asnagli H, Murphy KM. T helper subset development: roles of instruction, selection, and transcription. J Clin Invest. 2002;109(4):431–435. doi: 10.1172/JCI0215093.
    1. Palomares O, Martin-Fontecha M, Lauener R, Traidl-Hoffmann C, Cavkaytar O, Akdis M, Akdis CA. Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-beta. Genes Immun. 2014;15(8):511–520. doi: 10.1038/gene.2014.45.
    1. Hsieh CS, Heimberger AB, Gold JS, O’Garra A, Murphy KM. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system. Proc Natl Acad Sci U S A. 1992;89(13):6065–6069. doi: 10.1073/pnas.89.13.6065.
    1. Ramos HJ, Davis AM, Cole AG, Schatzle JD, Forman J, Farrar JD. Reciprocal responsiveness to interleukin-12 and interferon-alpha specifies human CD8+ effector versus central memory T-cell fates. Blood. 2009;113(22):5516–5525. doi: 10.1182/blood-2008-11-188458.
    1. Huber JP, Ramos HJ, Gill MA, Farrar JD. Cutting edge: Type I IFN reverses human Th2 commitment and stability by suppressing GATA3. J Immunol. 2010;185(2):813–817. doi: 10.4049/jimmunol.1000469.
    1. Huber JP, Farrar JD. Regulation of effector and memory T-cell functions by type I interferon. Immunology. 2011;132(4):466–474. doi: 10.1111/j.1365-2567.2011.03412.x.
    1. Fujio K, Okamura T, Yamamoto K. The family of IL-10-secreting CD4+ T cells. Adv Immunol. 2010;105:99–130. doi: 10.1016/S0065-2776(10)05004-2.
    1. Ramer-Quinn DS, Baker RA, Sanders VM. Activated T helper 1 and T helper 2 cells differentially express the beta-2-adrenergic receptor: a mechanism for selective modulation of T helper 1 cell cytokine production. J Immunol. 1997;159(10):4857–4867.
    1. Sanders VM, Baker RA, Ramer-Quinn DS, Kasprowicz DJ, Fuchs BA, Street NE. Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J Immunol. 1997;158(9):4200–4210.
    1. Slota C, Shi A, Chen G, Bevans M, Weng NP. Norepinephrine preferentially modulates memory CD8 T cell function inducing inflammatory cytokine production and reducing proliferation in response to activation. Brain Behav Immun. 2015;46:168–179. doi: 10.1016/j.bbi.2015.01.015.
    1. Estrada LD, Ağaç D, Farrar JD. Sympathetic neural signaling via the β2-adrenergic receptor suppresses T-cell receptor-mediated human and mouse CD8(+) T-cell effector function. Eur J Immunol. 2016;46(8):1948–1958. doi: 10.1002/eji.201646395.
    1. Davis AM, Hagan KA, Matthews LA, Bajwa G, Gill MA, Gale M, Jr, Farrar JD. Blockade of virus infection by human CD4+ T cells via a cytokine relay network. J Immunol. 2008;180(10):6923–6932. doi: 10.4049/jimmunol.180.10.6923.
    1. Diaz-Salazar C, Bou-Puerto R, Mujal AM, Lau CM, von Hoesslin M, Zehn D, Sun JC (2020) Cell-intrinsic adrenergic signaling controls the adaptive NK cell response to viral infection. J Exp Med 214(4):e20190554. 10.1084/jem.20190549
    1. Wahle M, Stachetzki U, Krause A, Pierer M, Hantzschel H, Baerwald CG. Regulation of beta2-adrenergic receptors on CD4 and CD8 positive lymphocytes by cytokines in vitro. Cytokine. 2001;16(6):205–209. doi: 10.1006/cyto.2001.0965.
    1. Grebe KM, Hickman HD, Irvine KR, Takeda K, Bennink JR, Yewdell JW. Sympathetic nervous system control of anti-influenza CD8+ T cell responses. Proc Natl Acad Sci U S A. 2009;106(13):5300–5305. doi: 10.1073/pnas.0808851106.
    1. Kim SB, Han YW, Rahman MM, Kim SJ, Yoo DJ, Kang SH, Kim K, Eo SK. Modulation of protective immunity against herpes simplex virus via mucosal genetic co-transfer of DNA vaccine with beta2-adrenergic agonist. Exp Mol Med. 2009;41(11):812–823. doi: 10.3858/emm.2009.41.11.087.
    1. Dugger KJ, Chrisman T, Sayner SL, Chastain P, Watson K, Estes R. Beta-2 adrenergic receptors increase TREG cell suppression in an OVA-induced allergic asthma mouse model when mice are moderate aerobically exercised. BMC Immunol. 2018;19(1):9. doi: 10.1186/s12865-018-0244-1.
    1. Nijhuis LE, Olivier BJ, Dhawan S, Hilbers FW, Boon L, Wolkers MC, Samsom JN, de Jonge WJ. Adrenergic beta2 receptor activation stimulates anti-inflammatory properties of dendritic cells in vitro. PLoS One. 2014;9(1):e85086. doi: 10.1371/journal.pone.0085086.
    1. Wang J, Yu L, Jiang C, Fu X, Liu X, Wang M, Ou C, Cui X, Zhou C, Wang J. Cerebral ischemia increases bone marrow CD4+CD25+FoxP3+ regulatory T cells in mice via signals from sympathetic nervous system. Brain Behav Immun. 2015;43:172–183. doi: 10.1016/j.bbi.2014.07.022.
    1. Eijkelkamp N, Cobelens PM, Sanders VM, Heijnen CJ, Kavelaars A. Tissue specific effects of the beta 2-adrenergic agonist salbutamol on LPS-induced IFN-gamma, IL-10 and TGF-beta responses in vivo. J Neuroimmunol. 2004;150(1-2):3–9. doi: 10.1016/j.jneuroim.2004.01.001.
    1. Vida G, Pena G, Kanashiro A, Thompson-Bonilla Mdel R, Palange D, Deitch EA, Ulloa L. beta2-Adrenoreceptors of regulatory lymphocytes are essential for vagal neuromodulation of the innate immune system. FASEB J. 2011;25(12):4476–4485. doi: 10.1096/fj.11-191007.
    1. Chavan SS, Pavlov VA, Tracey KJ. Mechanisms and Therapeutic Relevance of Neuro-immune Communication. Immunity. 2017;46(6):927–942. doi: 10.1016/j.immuni.2017.06.008.
    1. Pavlov VA, Tracey KJ. Neural regulation of immunity: molecular mechanisms and clinical translation. Nat Neurosci. 2017;20(2):156–166. doi: 10.1038/nn.4477.
    1. Bonaz B, Sinniger V, Pellissier S. Anti-inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation. J Physiol. 2016;594(20):5781–5790. doi: 10.1113/JP271539.
    1. Rosas-Ballina M, Olofsson PS, Ochani M, Valdes-Ferrer SI, Levine YA, Reardon C, Tusche MW, Pavlov VA, Andersson U, Chavan S, Mak TW, Tracey KJ. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science. 2011;334(6052):98–101. doi: 10.1126/science.1209985.
    1. Olofsson PS, Katz DA, Rosas-Ballina M, Levine YA, Ochani M, Valdes-Ferrer SI, Pavlov VA, Tracey KJ, Chavan SS. alpha7 nicotinic acetylcholine receptor (alpha7nAChR) expression in bone marrow-derived non-T cells is required for the inflammatory reflex. Mol Med. 2012;18:539–543. doi: 10.2119/molmed.2011.00405.
    1. Takenaka MC, Guereschi MG, Basso AS. Neuroimmune interactions: dendritic cell modulation by the sympathetic nervous system. Semin Immunopathol. 2017;39(2):165–176. doi: 10.1007/s00281-016-0590-0.
    1. Guyot M, Simon T, Panzolini C, Ceppo F, Daoudlarian D, Murris E, Macia E, Abelanet S, Sridhar A, Vervoordeldonk MJ, Glaichenhaus N, Blancou P. Apical splenic nerve electrical stimulation discloses an anti-inflammatory pathway relying on adrenergic and nicotinic receptors in myeloid cells. Brain Behav Immun. 2019;80:238–246. doi: 10.1016/j.bbi.2019.03.015.
    1. Haerter K, Vroon A, Kavelaars A, Heijnen CJ, Limmroth V, Espinosa E, Schedlowski M, Elsenbruch S. In vitro adrenergic modulation of cellular immune functions in experimental autoimmune encephalomyelitis. J Neuroimmunol. 2004;146(1-2):126–132. doi: 10.1016/j.jneuroim.2003.10.051.
    1. Simonini MV, Polak PE, Sharp A, McGuire S, Galea E, Feinstein DL. Increasing CNS noradrenaline reduces EAE severity. J Neuroimmune Pharmacol. 2010;5(2):252–259. doi: 10.1007/s11481-009-9182-2.
    1. Shaked I, Hanna RN, Shaked H, Chodaczek G, Nowyhed HN, Tweet G, Tacke R, Basat AB, Mikulski Z, Togher S, Miller J, Blatchley A, Salek-Ardakani S, Darvas M, Kaikkonen MU, Thomas GD, Lai-Wing-Sun S, Rezk A, Bar-Or A, Glass CK, Bandukwala H, Hedrick CC. Transcription factor Nr4a1 couples sympathetic and inflammatory cues in CNS-recruited macrophages to limit neuroinflammation. Nat Immunol. 2015;16(12):1228–1234. doi: 10.1038/ni.3321.
    1. Araujo LP, Maricato JT, Guereschi MG, Takenaka MC, Nascimento VM, de Melo FM, Quintana FJ, Brum PC, Basso AS. The sympathetic nervous system mitigates CNS autoimmunity via beta2-adrenergic receptor signaling in immune cells. Cell Rep. 2019;28(12):3120–3130. doi: 10.1016/j.celrep.2019.08.042.
    1. Cosentino M, Zaffaroni M, Legnaro M, Bombelli R, Schembri L, Baroncini D, Bianchi A, Clerici R, Guidotti M, Banfi P, Bono G, Marino F. Dopaminergic receptors and adrenoceptors in circulating lymphocytes as putative biomarkers for the early onset and progression of multiple sclerosis. J Neuroimmunol. 2016;298:82–89. doi: 10.1016/j.jneuroim.2016.07.008.
    1. Albertson TE, Chenoweth JA, Pearson SJ, Murin S. The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS) Expert Opin Pharmacother. 2020;21(2):213–231. doi: 10.1080/14656566.2019.1701656.
    1. Antonioli L, Blandizzi C, Pacher P, Hasko G. The purinergic system as a pharmacological target for the treatment of immune-mediated inflammatory diseases. Pharmacol Rev. 2019;71(3):345–382. doi: 10.1124/pr.117.014878.
    1. Akdis CA, Arkwright PD, Bruggen MC, Busse W, Gadina M, Guttman-Yassky E, Kabashima K, Mitamura Y, Vian L, Wu J, Palomares O. Type 2 immunity in the skin and lungs. Allergy. 2020;75(7):1582–1605. doi: 10.1111/all.14318.
    1. Huang C, Li F, Wang J, Tian Z (2019) Innate-like lymphocytes and innate lymphoid cells in asthma. Clin Rev Allergy Immunol. 10.1007/s12016-019-08773-6
    1. Lambrecht BN, Hammad H, Fahy JV. The cytokines of asthma. Immunity. 2019;50(4):975–991. doi: 10.1016/j.immuni.2019.03.018.
    1. Hinks TSC, Hoyle RD, Gelfand EW. CD8(+) Tc2 cells: underappreciated contributors to severe asthma. Eur Respir Rev. 2019;28(154):190092. doi: 10.1183/16000617.0092-2019.
    1. Moriyama S, Brestoff JR, Flamar AL, Moeller JB, Klose CSN, Rankin LC, Yudanin NA, Monticelli LA, Putzel GG, Rodewald HR, Artis D. beta2-adrenergic receptor-mediated negative regulation of group 2 innate lymphoid cell responses. Science. 2018;359(6379):1056–1061. doi: 10.1126/science.aan4829.
    1. Gonzales-van Horn SR, Farrar JD. Interferon at the crossroads of allergy and viral infections. J Leukoc Biol. 2015;98(2):185–194. doi: 10.1189/jlb.3RU0315-099R.
    1. Gonzales-van Horn SR, Estrada LD, van Oers NS, Farrar JD. STAT4-mediated transcriptional repression of the IL5 gene in human memory Th2 cells. Eur J Immunol. 2016;46(6):1504–1510. doi: 10.1002/eji.201546050.
    1. Chen F, Rowe RK, Gill MA, Farrar JD. Type I interferon suppresses memory Th2 cell cytokine secretion from allergic subjects. Allergy. 2019;75:695–698. doi: 10.1111/all.14056.
    1. Huber JP, Gonzales-van Horn SR, Roybal KT, Gill MA, Farrar JD. IFN-alpha suppresses GATA3 transcription from a distal exon and promotes H3K27 trimethylation of the CNS-1 enhancer in human Th2 cells. J Immunol. 2014;192(12):5687–5694. doi: 10.4049/jimmunol.1301908.
    1. Gill MA. The role of dendritic cells in asthma. J Allergy Clin Immunol. 2012;129(4):889–901. doi: 10.1016/j.jaci.2012.02.028.
    1. Rowe RK, Gill MA. Asthma: the interplay between viral infections and allergic diseases. Immunol Allergy Clin North Am. 2015;35(1):115–127. doi: 10.1016/j.iac.2014.09.012.
    1. Gill MA, Bajwa G, George TA, Dong CC, Dougherty II, Jiang N, Gan VN, Gruchalla RS. Counterregulation between the FcepsilonRI pathway and antiviral responses in human plasmacytoid dendritic cells. J Immunol. 2010;184(11):5999–6006. doi: 10.4049/jimmunol.0901194.
    1. Bajwa G, DeBerardinis RJ, Shao B, Hall B, Farrar JD, Gill MA. Cutting edge: critical role of glycolysis in human plasmacytoid dendritic cell antiviral responses. J Immunol. 2016;196(5):2004–2009. doi: 10.4049/jimmunol.1501557.
    1. Gill MA, Liu AH, Calatroni A, Krouse RZ, Shao B, Schiltz A, Gern JE, Togias A, Busse WW. Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab. J Allergy Clin Immunol. 2017;141:1735–1743.e9. doi: 10.1016/j.jaci.2017.07.035.
    1. Rowe RK, Pyle DM, Farrar JD, Gill MA. IgE-mediated regulation of IL-10 and type I IFN enhances rhinovirus-induced Th2 differentiation by primary human monocytes. Eur J Immunol. 2020;50(10):1550–1559. doi: 10.1002/eji.201948396.
    1. Kato G, Takahashi K, Tashiro H, Kurata K, Shirai H, Kimura S, Hayashi S. beta2 adrenergic agonist attenuates house dust mite-induced allergic airway inflammation through dendritic cells. BMC Immunol. 2014;15:39. doi: 10.1186/s12865-014-0039-y.
    1. Scheiermann C, Kunisaki Y, Frenette PS. Circadian control of the immune system. Nat Rev Immunol. 2013;13(3):190–198. doi: 10.1038/nri3386.
    1. Cermakian N, Lange T, Golombek D, Sarkar D, Nakao A, Shibata S, Mazzoccoli G. Crosstalk between the circadian clock circuitry and the immune system. Chronobiol Int. 2013;30(7):870–888. doi: 10.3109/07420528.2013.782315.
    1. Geiger SS, Fagundes CT, Siegel RM. Chrono-immunology: progress and challenges in understanding links between the circadian and immune systems. Immunology. 2015;146(3):349–358. doi: 10.1111/imm.12525.
    1. Cermakian N, Sassone-Corsi P. Environmental stimulus perception and control of circadian clocks. Curr Opin Neurobiol. 2002;12(4):359–365. doi: 10.1016/s0959-4388(02)00347-1.
    1. Labrecque N, Cermakian N. Circadian clocks in the immune system. J Biol Rhythms. 2015;30(4):277–290. doi: 10.1177/0748730415577723.
    1. Nakai A, Hayano Y, Furuta F, Noda M, Suzuki K. Control of lymphocyte egress from lymph nodes through beta2-adrenergic receptors. J Exp Med. 2014;211(13):2583–2598. doi: 10.1084/jem.20141132.
    1. Suzuki K, Hayano Y, Nakai A, Furuta F, Noda M. Adrenergic control of the adaptive immune response by diurnal lymphocyte recirculation through lymph nodes. J Exp Med. 2016;213(12):2567–2574. doi: 10.1084/jem.20160723.
    1. Silver AC, Arjona A, Walker WE, Fikrig E. The circadian clock controls toll-like receptor 9-mediated innate and adaptive immunity. Immunity. 2012;36(2):251–261. doi: 10.1016/j.immuni.2011.12.017.
    1. Dimitrov S, Lange T, Gouttefangeas C, Jensen ATR, Szczepanski M, Lehnnolz J, Soekadar S, Rammensee HG, Born J, Besedovsky L. Galphas-coupled receptor signaling and sleep regulate integrin activation of human antigen-specific T cells. J Exp Med. 2019;216(3):517–526. doi: 10.1084/jem.20181169.
    1. Bollinger T, Leutz A, Leliavski A, Skrum L, Kovac J, Bonacina L, Benedict C, Lange T, Westermann J, Oster H, Solbach W. Circadian clocks in mouse and human CD4+ T cells. PLoS One. 2011;6(12):e29801. doi: 10.1371/journal.pone.0029801.
    1. Hemmers S, Rudensky AY. The cell-intrinsic circadian clock is dispensable for lymphocyte differentiation and function. Cell Rep. 2015;11(9):1339–1349. doi: 10.1016/j.celrep.2015.04.058.
    1. Nobis CC, Dubeau Laramee G, Kervezee L, Maurice De Sousa D, Labrecque N, Cermakian N. The circadian clock of CD8 T cells modulates their early response to vaccination and the rhythmicity of related signaling pathways. Proc Natl Acad Sci U S A. 2019;116(40):20077–20086. doi: 10.1073/pnas.1905080116.
    1. Brooks JF 2nd, Hooper LV (2020) Interactions among microbes, the immune system, and the circadian clock. Semin Immunopathol. 10.1007/s00281-020-00820-1
    1. Butler TD, Gibbs JE. Circadian host-microbiome interactions in immunity. Front Immunol. 2020;11:1783. doi: 10.3389/fimmu.2020.01783.
    1. Rosser EC, Piper CJM, Matei DE, Blair PA, Rendeiro AF, Orford M, Alber DG, Krausgruber T, Catalan D, Klein N, Manson JJ, Drozdov I, Bock C, Wedderburn LR, Eaton S, Mauri C. Microbiota-derived metabolites suppress arthritis by amplifying aryl-hydrocarbon receptor activation in regulatory B cells. Cell Metab. 2020;31(4):837–851. doi: 10.1016/j.cmet.2020.03.003.
    1. Hang S, Paik D, Yao L, Kim E, Trinath J, Lu J, Ha S, Nelson BN, Kelly SP, Wu L, Zheng Y, Longman RS, Rastinejad F, Devlin AS, Krout MR, Fischbach MA, Littman DR, Huh JR. Bile acid metabolites control TH17 and Treg cell differentiation. Nature. 2019;576(7785):143–148. doi: 10.1038/s41586-019-1785-z.
    1. Campbell C, McKenney PT, Konstantinovsky D, Isaeva OI, Schizas M, Verter J, Mai C, Jin WB, Guo CJ, Violante S, Ramos RJ, Cross JR, Kadaveru K, Hambor J, Rudensky AY. Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells. Nature. 2020;581(7809):475–479. doi: 10.1038/s41586-020-2193-0.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren